Clinical Usefulness of a Prognostic Score in Histological Analysis of Renal Biopsy in Patients with Lupus Nephritis

被引:29
作者
Kojo, Shoichiro [1 ]
Sada, Ken-Ei [1 ]
Kobayashi, Mizuho [1 ]
Maruyama, Mie [1 ]
Maeshima, Yohei [1 ]
Sugiyama, Hitoshi [1 ]
Makino, Hirofumi [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan
关键词
LUPUS NEPHRITIS; PROGNOSIS SCORING SYSTEM; RENAL OUTCOME; INTERNATIONAL SOCIETY OF NEPHROLOGY/RENAL PATHOLOGY SOCIETY CLASSIFICATION; GLOMERULONEPHRITIS; CLASSIFICATION; PATHOGENESIS; FEATURES;
D O I
10.3899/jrheum.080793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To evaluate active and chronic lesions in association with renal outcome according to the International Society of Nephrology/Renal Pathology Society classification in patients with lupus nephritis. Methods. A retrospective analysis of 99 biopsy-proven subjects with lupus nephritis from 1990 to 2006 was performed in our center using the new classification. Each histological lesion was evaluated by multivariate survival analysis as predictive factor for renal insufficiency in patients with lupus nephritis, and independent predictors were graded to develop the prognostic score based on the regression coefficient. A receiver operating-characteristic curve based on the prognostic score was plotted to determine the most appropriate cutoff point. Results. In class IV, the IV-G group tended to exhibit a worse renal outcome compared with the IV-S group, but the difference was not significant (log-rank test, p = 0.4330). Independent histological predictors of poor renal outcome were extracapillary proliferation, glomerular sclerosis, and fibrous crescents analyzed by Cox proportional hazards model, while predictors of favorable renal outcome were hyaline thrombi and fibrous adhesions. By the prognostic score, renal outcome was significantly worse in the group with the higher score (>= 0.25) than in the group with the lower score (< 0.25) in class IV patients (log-rank test, p < 0.001). Conclusion. These results demonstrate the advantage of our prognostic score compared to subclasses in predicting the renal outcome of class IV patients [University Hospital Medical Information Network (UMIN) clinical trials registry, number UMIN 000001943]. (First Release Aug 1 2009; J Rheumatol 2009,36:2218-23; doi: 10.3899/jrheum.080793)
引用
收藏
页码:2218 / 2223
页数:6
相关论文
共 17 条
[1]  
Abraham M A, 1999, J Assoc Physicians India, V47, P862
[2]   PREDICTING RENAL OUTCOMES IN SEVERE LUPUS NEPHRITIS - CONTRIBUTIONS OF CLINICAL AND HISTOLOGIC DATA [J].
AUSTIN, HA ;
BOUMPAS, DT ;
VAUGHAN, EM ;
BALOW, JE .
KIDNEY INTERNATIONAL, 1994, 45 (02) :544-550
[3]  
AUSTIN HA, 1995, NEPHROL DIAL TRANSPL, V10, P1620
[4]  
AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
[5]   PROGNOSTIC FACTORS IN LUPUS NEPHRITIS - CONTRIBUTION OF RENAL HISTOLOGIC DATA [J].
AUSTIN, HA ;
MUENZ, LR ;
JOYCE, KM ;
ANTONOVYCH, TA ;
KULLICK, ME ;
KLIPPEL, JH ;
DECKER, JL ;
BALOW, JE .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (03) :382-391
[6]   Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis - A UK-wide study [J].
Furness, Peter N. ;
Taub, Nick .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (08) :1030-1035
[7]   Class IV-S versus class IV-G lupus nephritis:: Clinical and morphologic differences suggesting different pathogenesis [J].
Hill, GS ;
Delahousse, M ;
Nochy, D ;
Bariéty, J .
KIDNEY INTERNATIONAL, 2005, 68 (05) :2288-2297
[8]   Predictive power of the second renal biopsy in lupus nephritis:: Significance of macrophages [J].
Hill, GS ;
Delahousse, M ;
Nochy, D ;
Rémy, P ;
Mignon, F ;
Méry, JP ;
Bariéty, J .
KIDNEY INTERNATIONAL, 2001, 59 (01) :304-316
[9]   Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan [J].
Imai, Enyu ;
Horio, Masaru ;
Nitta, Kosaku ;
Yamagata, Kunihiro ;
Iseki, Kunitoshi ;
Tsukamoto, Yusuke ;
Ito, Sadayoshi ;
Makino, Hirofumi ;
Hishida, Akira ;
Matsuo, Seiichi .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (06) :927-937
[10]  
Mitjavila F, 1997, CLIN EXP RHEUMATOL, V15, P625